Latest news from eBioMedicine on Newswise en-us Copyright 2024 Newswise 115 31 / /images/newswise-logo-rss.gif /articles/mesenchymal-nbsp-stem-cell-nbsp-treatment-for-covid-19/?sc=rsin /articles/mesenchymal-nbsp-stem-cell-nbsp-treatment-for-covid-19/?sc=rsin Tue, 15 Mar 2022 09:00:15 EST ... In addition, MSCs derived from different donors and tissues lead to individual heterogeneity, which complicates the progress of consistent and standardized stem cell production. Therefore, it is necessary to screen qualified MSCs to avoid uncertain effects. ... eBioMedicine